Pfizer is evaluating the costs for developing a new biopharmaceutical drug. Fixed research and development (R&D) costs are $800 million, and variable costs per unit are $1,000. Pfizer plans to produce 1 million units in the first year. Additionally, clinical trial expenses are estimated at $300 million, and marketing and distribution costs are projected to be $200 million.

Requirements:

• Calculate the total R&D, clinical trial, and marketing costs for the new biopharmaceutical drug.
• Determine the cost per unit of the drug.
• Analyze the impact of producing an additional 200,000 units beyond the initial plan.
• Discuss the strategic importance of clinical trials and marketing in launching new pharmaceutical products.
• Evaluate the total cost of developing Pfizer's new biopharmaceutical drug.
• Recommend strategies for managing costs and maximizing market penetration.